NASDAQ · PAHC
Phibro Animal Health Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for PAHC: Nov 04, 2026
Phibro Animal Health Corporation Class A Common Stock is expected to report earnings on 11/04/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $0.79. The reported EPS for the same quarter last year was $0.73.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.79 | $0.81 | $0.78 | 3 |
| Dec 2026 | $0.94 | $0.97 | $0.91 | 3 |
| Mar 2027 | $0.86 | $0.92 | $0.83 | 3 |
| Jun 2027 | $0.89 | $0.90 | $0.88 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks- Zacks · Oct 29, 11:06 AM EDTALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock FallsAlign Technology's Q3 earnings and revenues beat estimates on higher aligner shipments, but a lowered 2026 sales outlook weighs on shares.
- Zacks · Oct 29, 10:43 AM EDTBTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?BrightSpring gears up for Q3 earnings, with strong Specialty, Infusion and Provider Services growth expected to offset IRA headwinds. Can it beat estimates?
- Zacks · Oct 29, 9:46 AM EDTZimmer Biomet Gears Up to Report Q3 Earnings: What's in the Cards?ZBH heads into Q3 earnings with growth expected in Hips, S.E.T. and Technology & Data, while Knee sales face ongoing pressure.
- Zacks · Oct 28, 2:45 PM EDTUHS Misses Q3 Earnings Estimates Despite Higher Patient VolumesUniversal Health Services' Q3 earnings fall 8.3% despite revenue growth, as rising costs and Acute Care pricing pressure offset higher patient volumes.
- Zacks · Oct 28, 12:51 PM EDTWaters Gears Up to Report Q3 Results: How to Play the Stock?WAT's Q3 results are likely to benefit from strong revenue growth prospects, rising demand and acquisition gains.
- Zacks · Oct 28, 9:30 AM EDTNTRA Q3 Earnings on Deck: Will Signatera Volume Growth Drive Results?Natera's third-quarter 2026 results hinge on Signatera volume growth, regulatory milestones and higher test prices, while expanding Medicare coverage may boost organ health revenues.
- Zacks · Oct 28, 9:24 AM EDTLH Stock Rises on Q3 Earnings and Revenue Beat, '26 View UpLabcorp shares rise as Q3 earnings and revenues beat estimates, both segments deliver growth, margins expand and the company raises its 2026 financial outlook.
- Zacks · Oct 28, 9:00 AM EDTPhibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?Phibro (PAHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 27, 11:14 AM EDTACB's Q2 Earnings on Deck: International Medical Cannabis in FocusAurora Cannabis heads into Q2 earnings with revenues expected to fall 20.1%, as market exits and reimbursement cuts weigh on results while international medical cannabis markets offer support.
- Zacks · Oct 27, 10:49 AM EDTCentene Q3 Earnings Beat Estimates on Medicare StrengthCentene's Q3 earnings beat estimates as Medicare revenues surge 19.9% despite falling membership, while management lifts its 2026 adjusted profit outlook.
- Zacks · Oct 27, 8:40 AM EDTShould Value Investors Buy Phibro Animal Health (PAHC) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- Zacks · Oct 26, 12:59 PM EDTDexCom Gears Up to Report Q3 Results: How to Play the Stock?DXCM Q3 earnings are likely to benefit from CGM adoption, G7 15 Day uptake and wider reimbursement amid tougher international comparisons.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Phibro Animal Health Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.